Patents Assigned to Envoy Therapeutics, Inc.
  • Patent number: 8513485
    Abstract: The invention provides methods for isolating cell-type specific mRNAs by selectively isolating ribosomes or proteins that bind mRNA in a cell type specific manner, and, thereby, the mRNA hound to the ribosomes or proteins that bind mRNA. Ribosomes, which are riboprotein complexes, bind mRNA that is being actively translated in cells. According to the methods of the invention, cells are engineered to express a molecularly tagged ribosomal protein or protein that binds mRNA by introducing into the cell a nucleic acid comprising a nucleotide sequence encoding a ribosomal protein or protein that binds mRNA fused to a nucleotide sequence encoding a peptide tag. The tagged ribosome or mRNA binding protein can then be isolated, along with the mRNA bound to the tagged ribosome or mRNA binding protein, and the mRNA isolated and further used for gene expression analysis.
    Type: Grant
    Filed: May 10, 2011
    Date of Patent: August 20, 2013
    Assignee: Envoy Therapeutics, Inc.
    Inventors: Nathaniel Heintz, Tito A. Serafini, Andrew W. Shyjan